SCHEMBL29907178

SCHEMBL29907178

COc1cc2[nH]ncc2nc1Cl

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.50
PGK1 P00558 3/20 0.41
TLR8 Q9NR97 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
TRPA1 O75762 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAOB P27338 3/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAOA P21397 1/20 0.37
NOS1 P29475 2/20 0.37
DYRK1A Q13627 2/20 0.37
BRD4 O60885 1/20 0.36
AURKA O14965 1/20 0.36
RET P07949 2/20 0.35
KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210862 1.00 AXL (0.50) AXLPGK1TLR8MKNK1TRPA1
SCHEMBL26632171 0.78 NOS1 (0.41) TRPA1KDM4EALDH1A1MEN1KMT2A
SCHEMBL31133339 0.76 NOS1 (0.42) TRPA1TRPM8KDM4EALDH1A1MAOB
SCHEMBL3560175 0.72 AXL (0.73) AXLTLR8MKNK1TRPA1TRPM8
SCHEMBL29109556 0.70 AXL (0.60) AXLTLR8MKNK1TRPA1TRPM8
SCHEMBL33527188 0.70 KHK (0.42) TRPA1ALDH1A1SMN1; SMN2NOS1DYRK1A
SCHEMBL29509917 0.69 KMO (0.46) TLR8TRPA1KDM4EALDH1A1SMN1; SMN2
SCHEMBL25341600 0.69 KMO (0.46) TLR8TRPA1KDM4EALDH1A1SMN1; SMN2
SCHEMBL20617830 0.68 AXL (0.67) AXLTLR8MKNK1TRPA1TRPM8
SCHEMBL31599741 0.68 TRPA1 (0.40) TRPA1KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115835908-A Bicyclic heterocycles as FGFR inhibitors 因赛特公司 2023-03-21 CN disclosed
EP-4045151-A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Incyte Corporation (US) 2022-08-24 EP disclosed